Clinicians should be aware of the increased risk for lymphoproliferative disorders, including pulmonary Non Hodgkin's Lymphoma in scleroderma patients. CHEST, 10/27/2015. (Also see Correlation of Pulmonary Fibrosis and Cancer and Cancer and Scleroderma)
This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.